Investigational AstraZeneca vaccine prevents COVID-19

Results from a large clinical trial in the United States and South America indicate that AstraZeneca’s COVID-19 vaccine, AZD1222, is well-tolerated and protects against symptomatic COVID-19 disease, including severe disease or hospitalization. The independent Data and Safety Monitoring Board (DSMB) overseeing the trial identified no safety concerns related to the vaccine. The United Kingdom-based global…

Details

COVID-19: Scientists, doctors launch virtual town halls to address vaccine concerns

More than 50 scientific experts from across the United States, including virologists, infectious disease specialists and medical doctors, are launching a series of virtual town halls to answer the public’s questions about the COVID-19 vaccines. The effort aims to bring factual, scientific information to people across the country, particularly communities of color that have been…

Details

A project by Russian scientists will help create capsules for targeted drug delivery

Scientists from MIPT and ITMO University and their colleagues have studied the formation and growth of crystals from simple organic molecules into large associations. These experiments will help create capsules for targeted drug delivery to specific tissues in the human body. The scientific paper was published in the journal Crystal Growth & Design. Melamine cyanurate…

Details

Cancer study highlights racial disparities for patients facing dual diagnoses

The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology, showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection. After reviewing detailed information from almost 5,000 patients with active or past cancer and laboratory-confirmed COVID-19 diagnosis, CCC19 study authors found associations among laboratory measures, clinical factors…

Details

Investigational gene regulation therapy could protect against Alzheimer’s

Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer’s in laboratory studies. It leverages zinc finger proteins, which specifically bind to the DNA that codes for the protein Tau without altering it,…

Details